Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?
Elise van MulligenMaureen Rutten-van MölkenAnnette van der Helm-van MilPublished in: Annals of the rheumatic diseases (2024)
When RA is detected within 12 weeks after symptom onset, treatment-related costs were lower in both autoantibody-negative and autoantibody-positive RA. This study is the first to report how early diagnosis and treatment start impact treatment-related costs.